Autumn Glory Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Autumn Glory Partners's NVO Position: Q2 2026 in Review
Autumn Glory Partners opened a new position in Novo Nordisk (NVO) in Q2 2026: 99,888 shares worth $4.79M. The stake represents 1.36% of the portfolio and ranks #16 among its holdings. This is a return to the name: Autumn Glory Partners previously reported a position in NVO as recently as Q4 2025.
Autumn Glory Partners first reported a position in NVO in Q4 2021 and has held it in 17 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Autumn Glory Partners held 99,888 shares of Novo Nordisk worth $4.79M as of Q2 2026.
- Novo Nordisk was a new Autumn Glory Partners position in Q2 2026.
- Novo Nordisk made up 1.36% of Autumn Glory Partners's portfolio in Q2 2026, its #16 holding.
- Autumn Glory Partners first reported a position in Novo Nordisk in Q4 2021 and has held it in 17 quarters since.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.